JP2014500302A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014500302A5 JP2014500302A5 JP2013545520A JP2013545520A JP2014500302A5 JP 2014500302 A5 JP2014500302 A5 JP 2014500302A5 JP 2013545520 A JP2013545520 A JP 2013545520A JP 2013545520 A JP2013545520 A JP 2013545520A JP 2014500302 A5 JP2014500302 A5 JP 2014500302A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccine
- canine
- bronchiseptica
- influenza virus
- virus antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229960005486 vaccine Drugs 0.000 claims 22
- 239000000427 antigen Substances 0.000 claims 10
- 102000036639 antigens Human genes 0.000 claims 10
- 108091007433 antigens Proteins 0.000 claims 10
- 241000282465 Canis Species 0.000 claims 9
- 241000712461 unidentified influenza virus Species 0.000 claims 9
- 241001353878 Canine parainfluenza virus Species 0.000 claims 7
- 125000003118 aryl group Chemical group 0.000 claims 7
- 235000015872 dietary supplement Nutrition 0.000 claims 6
- 230000035772 mutation Effects 0.000 claims 5
- GLDQAMYCGOIJDV-UHFFFAOYSA-N 2,3-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC(O)=C1O GLDQAMYCGOIJDV-UHFFFAOYSA-N 0.000 claims 4
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 claims 4
- 239000002671 adjuvant Substances 0.000 claims 4
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 claims 4
- 201000010099 disease Diseases 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 208000015181 infectious disease Diseases 0.000 claims 4
- 241000588779 Bordetella bronchiseptica Species 0.000 claims 3
- 229940031348 multivalent vaccine Drugs 0.000 claims 3
- 229940082044 2,3-dihydroxybenzoic acid Drugs 0.000 claims 2
- 241001167018 Aroa Species 0.000 claims 2
- 241000282472 Canis lupus familiaris Species 0.000 claims 2
- 101100491986 Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) aromA gene Proteins 0.000 claims 2
- 101710154606 Hemagglutinin Proteins 0.000 claims 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 2
- 241001465754 Metazoa Species 0.000 claims 2
- 101710093908 Outer capsid protein VP4 Proteins 0.000 claims 2
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 claims 2
- 101710176177 Protein A56 Proteins 0.000 claims 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims 2
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims 2
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 claims 2
- 229940103272 aluminum potassium sulfate Drugs 0.000 claims 2
- 230000000890 antigenic effect Effects 0.000 claims 2
- 101150037081 aroA gene Proteins 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 102000039446 nucleic acids Human genes 0.000 claims 2
- 108020004707 nucleic acids Proteins 0.000 claims 2
- 150000007523 nucleic acids Chemical class 0.000 claims 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 2
- GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 claims 2
- 238000007910 systemic administration Methods 0.000 claims 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000000185 hemagglutinin Substances 0.000 claims 1
- 235000016709 nutrition Nutrition 0.000 claims 1
- 230000035764 nutrition Effects 0.000 claims 1
- 239000013589 supplement Substances 0.000 claims 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201061425855P | 2010-12-22 | 2010-12-22 | |
| US61/425,855 | 2010-12-22 | ||
| EP11152829 | 2011-02-01 | ||
| EP11152829.5 | 2011-02-01 | ||
| US201161556975P | 2011-11-08 | 2011-11-08 | |
| US61/556,975 | 2011-11-08 | ||
| PCT/IB2011/003100 WO2012085642A1 (en) | 2010-12-22 | 2011-12-21 | Vaccines with live bacterial isolates for systemic administration |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014500302A JP2014500302A (ja) | 2014-01-09 |
| JP2014500302A5 true JP2014500302A5 (enExample) | 2015-02-05 |
| JP6145046B2 JP6145046B2 (ja) | 2017-06-07 |
Family
ID=43628729
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013545520A Active JP6145046B2 (ja) | 2010-12-22 | 2011-12-21 | 全身投与用の生細菌単離株を含むワクチン |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8821852B2 (enExample) |
| EP (1) | EP2655403A1 (enExample) |
| JP (1) | JP6145046B2 (enExample) |
| CN (1) | CN103261214B (enExample) |
| BR (1) | BR112013015009B1 (enExample) |
| CA (2) | CA3219727A1 (enExample) |
| RU (1) | RU2593953C2 (enExample) |
| WO (1) | WO2012085642A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106729683B (zh) * | 2016-12-16 | 2019-12-03 | 青岛易邦生物工程有限公司 | 一种猪支气管败血波氏杆菌病疫苗 |
| EP3906049A1 (en) * | 2019-01-04 | 2021-11-10 | Boehringer Ingelheim Animal Health USA Inc. | Attenuated bordetella bronchiseptica strains, oral vaccines containing the attenuated strains, and methods of making & use thereof |
| US20220409484A1 (en) * | 2019-11-18 | 2022-12-29 | Elanco Us Inc. | Lyophilized cake in straight-walled vial |
| EP4076513A1 (en) * | 2019-12-18 | 2022-10-26 | Intervet International B.V. | Oral respiratory vaccine |
| EP3909971A1 (en) | 2020-09-28 | 2021-11-17 | Institute of Life Sciences (ILS) | Whole cell livestock vaccine for respiratory diseases |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8730037D0 (en) * | 1987-12-23 | 1988-02-03 | Wellcome Found | Vaccines |
| US5955089A (en) * | 1993-04-20 | 1999-09-21 | Uab Research Foundation | Strain selection of pneumococcal surface proteins |
| US5840556A (en) | 1996-05-08 | 1998-11-24 | The United States Of America As Represented By The Department Of Agriculture | Molecular genetic construction of vaccine strains of pasteurellaceae |
| EP0835928A1 (en) * | 1996-10-11 | 1998-04-15 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Berlin | Helicobacter pylori live vaccine |
| AUPR977601A0 (en) * | 2001-12-28 | 2002-01-31 | Delta Biotechnology Limited | Defective entities and uses therefor |
| PL378001A1 (pl) * | 2003-01-29 | 2006-02-20 | Pfizer Products Inc. | Szczepionki przeciw Bordetella bronchiseptica dla psów |
| US7959929B2 (en) | 2005-04-21 | 2011-06-14 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
| KR20110126726A (ko) * | 2005-10-07 | 2011-11-23 | 화이자 프로덕츠 인코포레이티드 | 개과 동물의 인플루엔자의 치료를 위한 백신 및 방법 |
| BRPI0707102B1 (pt) | 2006-03-10 | 2022-05-31 | Institut Pasteur De Lille | Composição imunogênica |
| EP2134359A4 (en) | 2007-02-23 | 2010-06-16 | Penn State Res Found | USE OF A NONVIRULENT BORDETELLA MUTANT AS LIVING VACCINE VECTOR |
| KR20080082883A (ko) * | 2007-03-09 | 2008-09-12 | 전남대학교산학협력단 | 약독화된 보르데텔라 브론키셉티카 (ｂｂｓ) 균주 및 그의제조 방법, 그를 포함하는 면역원성 조성물 및 그를 이용한포유동물의 ｂｂｓ 감염증을 치료 또는 예방하는 방법 |
| TWI468157B (zh) | 2009-04-29 | 2015-01-11 | Intervet Int Bv | 形成錠劑的方法，進行該方法的系統及包含該錠劑的包裝物 |
| CN101575586B (zh) * | 2009-05-31 | 2011-01-19 | 华中农业大学 | 一种支气管败血波氏杆菌基因缺失疫苗及应用 |
-
2011
- 2011-12-21 CA CA3219727A patent/CA3219727A1/en active Pending
- 2011-12-21 RU RU2013133856/10A patent/RU2593953C2/ru active
- 2011-12-21 CN CN201180061881.2A patent/CN103261214B/zh active Active
- 2011-12-21 US US13/995,740 patent/US8821852B2/en active Active
- 2011-12-21 JP JP2013545520A patent/JP6145046B2/ja active Active
- 2011-12-21 WO PCT/IB2011/003100 patent/WO2012085642A1/en not_active Ceased
- 2011-12-21 CA CA2821422A patent/CA2821422C/en active Active
- 2011-12-21 EP EP11815565.4A patent/EP2655403A1/en not_active Withdrawn
- 2011-12-21 BR BR112013015009-2A patent/BR112013015009B1/pt active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Vincent et al. | Swine influenza viruses: a North American perspective | |
| JP2014500302A5 (enExample) | ||
| JP2013518052A5 (enExample) | ||
| JP4769481B2 (ja) | ポリ−γ−グルタミン酸含有免疫補強剤組成物 | |
| US20180245052A1 (en) | Attenuated influenza vectors for the prevention and/or treatment of infectious diseases and for the treatment of oncological diseases | |
| BR112020011593A2 (pt) | Uma vacina para proteção contra streptococcus suis | |
| Kamphuis et al. | A virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A provides protection against viral challenge without priming for enhanced disease in cotton rats | |
| CA2879228C (en) | Attenuated swine influenza vaccines and methods of making and use thereof | |
| BR112021008646A2 (pt) | uma vacina para proteção contra streptococcus suis | |
| Zhang et al. | Vaccination with recombinant Lactococcus lactis expressing HA1-IgY Fc fusion protein provides protective mucosal immunity against H9N2 avian influenza virus in chickens | |
| JP2019514971A5 (enExample) | ||
| JP2010506926A5 (enExample) | ||
| Kimoto et al. | Intranasal influenza vaccination using a new synthetic mucosal adjuvant SF‐10: induction of potent local and systemic immunity with balanced Th1 and Th2 responses | |
| JP2015529677A5 (enExample) | ||
| JP2009511080A5 (enExample) | ||
| RU2013133856A (ru) | Вакцины с живыми бактериальными изолятами для системного введения | |
| JP2013518563A5 (enExample) | ||
| CN107961371A (zh) | 季节流感-rsv联合疫苗及其制备方法和应用 | |
| Gramer et al. | Epidemiology of swine influenza and implications of reassortment | |
| Kang et al. | A novel combined adjuvant strongly enhances mucosal and systemic immunity to low pathogenic avian influenza after oral immunization in ducks | |
| JP2013516469A5 (enExample) | ||
| CA2728374A1 (en) | Compositions comprising salmonella porins and uses thereof as adjuvants and vaccines | |
| CN101085348B (zh) | 用于禽流感灭活抗原的鼻腔免疫复合佐剂 | |
| Nazari et al. | Nanoparticles in the prevention, diagnosis, and treatment of the influenza virus | |
| JP2017525726A5 (enExample) |